Clinical Usefulness of 11C-MET PET and 201Tl SPECT for Differentiation of Recurrent Glioma from Radiation Necrosis

Neurologia medico-chirurgica

Volumn 38, Issue 6, 1998, Pages 342-348

  Sonoda, Yukihiko ^a   Kumabe, Toshihiro ^a   Takahashi, Toshiei ^a   Shirane, Reizo ^a   Yoshimoto, Takashi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

L methyl 11C methionine; positron emission tomography; radiation necrosis; recurrent glioma; single photon emission computed tomography; thallium 201

Indexed keywords

CARBON; DIAGNOSTIC AGENT; DRUG DERIVATIVE; METHIONINE; METHIONINE METHYL ESTER; THALLIUM; METHYLMETHIONINE C 11; RADIOPHARMACEUTICAL AGENT; THALLIUM 201; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN; BRAIN TUMOR; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; GLIOMA; HUMAN; MALE; MIDDLE AGED; NECROSIS; PATHOLOGY; RADIATION EXPOSURE; RADIATION INJURY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKULL IRRADIATION; TUMOR RECURRENCE; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIATION NECROSIS;

ADULT; BRAIN; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; CRANIAL IRRADIATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIOMA; HUMANS; MALE; METHIONINE; MIDDLE AGED; NECROSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIATION INJURIES; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032087005     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.38.342     Document Type: Article

References (27)

1. Ancri D, Basset JY, Lonchampt MF, Etarard C: Diagnosis of cerebral lesions of thallium-201. Radiology 128:417-422, 1978.
2. Atkins HL, Budinger TF, Lebowitz E, Ansari AN, Greene NW, Fairchild RC, Ellis KJ: Thallium-201 for medical use. Part 3: human distribution and physical imaging properties. J Nucl Med 18: 133-140, 1977.
3. Bergstrom M, Ericson K, Hagenfeldt L, Mosskin M, von Holst H, Noren G, Eriksson L, Ehrin E, Johnstrom P: PET study of methionine accumulation in glioma and normal brain tissue. J Comput Assist Tomogr 11: 208-212, 1987.
4. Black KL, Emerick T, Hoh C, Hawkins RA, Mazziotta J, Becker DP: Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. Neurol Res 16: 93-96, 1994.
5. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D: Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 71: 342-346, 1989.
6. Buchpiguel CA, Alavi JB, Alavi A, Lawrence CK: PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain. j Nucl Med 36: 159-164, 1995.
7. Carvalho PA, Schwartz RB, Alexander E III, Garada BM, Zimmerman RE, Loeffler JS, Holman BL: Detection of recurrent gliomas with quantitative thallium201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 77: 565-570, 1992.
8. Derlon JM, Bourdet C, Bustany P, Chatel M, Theron J, Darcel F, Syrota A: (11C)L-methionine uptake in gliomas. Neurosurgery 25: 720-728, 1989.
9. Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kuffa CV, Kessler RM, Johnston GS, Manning RG, Wolf AP: Glucose utilization of cerebral gliomas measured by [18F]fluorodeoxyglucose and positron emission tomography. Neurology 8: 1323-1329, 1986.
10. Di Chiro G, Oldfield E, Wright DC, De Michele D, Katz DA, Patronas NJ, Doppman JL, Larson SM, Ito M, Kuffa CV: Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors. AJR Am J Roentgenol 150: 189-197, 1988.
11. Dooms GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, Newton TH: Brain radiation lesions. MR imaging. Radiology 158: 149-155, 1986.
12. Francavilla T, Miletich RS, Di Chilo G, Patronas NJ, Rizzoli HV, Wright DC: Positron emission tomography in the detection of malignant degeneration of low-grade gliomas. Neurosurgery 24: 1-5, 1989.
13. Kahn D, Follett KA, Bushnell DL, Nathan MA, Piper JG, Madsen M, Kirchner PT: Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET. AJR Am J Roentgenol 163: 1459-1465, 1994.
14. Kameyama M, Shirane R, Itoh J, Sato K, Katakura R, Yoshimoto T, Hatazawa J, Itoh M, Ido T: The accumulation of 11C-methionine and histological grades in cerebral glioma patients studied with PET. Acta Neurochir (Wien) 104: 8-12, 1990.
15. Kim KT, Black KL, Marciano D, Mazziotta JC, Guze BH, Grafton S, Hawkins RA, Becker DP: Thallium 201 SPECT imaging of brain tumors. J Nucl Med 31: 965-969, 1990.
16. Kleihues P, Burger PC, Scheithauer BW (eds): World Health Organization International Histological Classification of Tumours. Berlin, Heidelberg, Springer Verlag, 1993, 112 pp.
17. Lilja A, Bergstrom M, Spannare B, Olson Y: Reliability of CT in assessing histopathological features of malignant supratentorial gliomas. J Comput Assist Tomogr 5: 625-634, 1984.
18. Lilja A, Lundqvist H, Olsen Y, Spannare S, Gullberg P, Långström B: Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions. Acta Radio] 30: 121-128, 1989.
19. Mountz JM, Stafford-Schuck K, McKeever PE, Taren J, Beierwaltes WH: Thallium-201 tumor/cardiac ratio estimation of residual astrocytoma. J Neurosurg 68: 705-709, 1988.
20. Ogawa T, Kanno I, Shishido F, Inugami A, Higano S, Fujita H, Murakami M, Uemura K, Yasui N, Mineura K, Kowada M: Clinical value of PET with 18F-fluorodeoxyglucose and l-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radio] 32: 197-202, 1991.
21. Onishi H, Koizumai K, Uchiyama G, Yamaguchi M, Okada J, Ogata H, Toyama H, Monzawa S, Oba H, Araki T, Nambu A, Ohtomo K: [Evaluation of malignancy and viability of brain tumors by 201Tl SPECT: The correlation between 201Tl SPECT and pathology, clinical progress and the intensity of enhancement on CT images]. Nippon Acta Radiologica 54: 1388-1398, 1994 (Jpn, with Eng abstract).
22. Patronas NJ, Di Chiro G, Brooks RA, DeLaPaz RL, Kornblith FL, Smith BH, Rizzoli IV, Kessler RM, Manning RG, Channing M, Wolf AP, O'Connor CM: Work in progress: [18F]fluorodeoxyglucose and PET in the evaluation of radiation necrosis of the brain. Radiology 144: 885-889, 1982.
23. Sato K, Kameyama M, Ishiwata K, Hatazawa J, Katakura R, Yoshimoto T: Dynamic study of methionine uptake in glioma using positron emission tomography. Eur J Nucl Med 19: 426-430, 1992.
24. Schwartz RB, Carvalho PA, Alexander E III, Loeffler JS, Folkerth R, Holman BL: Radiation necrosis vs high-grade recurrent glioma: differentiation by using dual-isotope SPECT with 201Tl and 99mTc-HMPAO. AJR Am J Roentgenol 12: 399-403, 1992.
25. Ueda T, Kaji Y, Wakisaka S, Watanabe K, Hoshi H, Jinnouchi S, Futami S: Time sequential single photon emission computed tomography studies in brain tumor using thallium-201. Eur J Nucl Med 20: 138-145, 1993.
26. Valk PE, Budinger TF, Levin VA, Silver P, Gutin PH, Doyle WK: PET of malignant cerebral tumors after interstitial brachytherapy. J Neurosurg 69: 830-838, 1988.
27. Yoshii Y, Satou M, Yamamoto T, Yamada Y, Hyodo A, Nose T, Ishikawa H, Hatakeyama R: The role of thallium single photon emission tomography in the investigation and characterization of brain tumors in man and their response to treatment. Eur J Nucl Med 20:39-45, 1992.